Q2 2019 Holdings
Filed 2019-08-14 | 87 holdings | $38.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $9.5M | 318,729 | 24.9% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $6.8M | 59,380 | 17.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $5.4M | 477,196 | 14.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.5M | 31,750 | 11.8% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $4.0M | 830,538 | 10.5% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.0M | 524,300 | 5.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.8M | 681,759 | 4.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.6M | 100,000 | 4.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.6M | 410,888 | 4.1% |
| Alector Inc(ALEC) | COM | 014442107 | $440.0K | 23,166 | 1.2% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $300.0K | 50,000 | 0.8% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $39.7K | 13,680,554 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $22.7K | 123,806 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $11.6K | 123,218 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $7.5K | 636,013 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $6.8K | 52,509 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $6.7K | 140,764 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.7K | 61,400 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $6.1K | 205,440 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $5.7K | 217,554 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $5.5K | 93,942 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $5.5K | 497,762 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.5K | 64,608 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.4K | 36,338 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $4.4K | 205,011 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $4.2K | 95,000 | 0.0% |
| Luminex Corp | COM | 55027E102 | $4.0K | 194,091 | 0.0% |
| Eloxx Pharmaceuticals Inc | COM | 29014R103 | $3.7K | 375,000 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.6K | $4,000,000 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $3.6K | 600,030 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.3K | 330,667 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $3.2K | 25,500 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $2.9K | 734,422 | 0.0% |
| Cortexyme Inc(QNCX) | COM | 22053A107 | $2.8K | 65,400 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $2.6K | 200,013 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.5K | 349,996 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $2.4K | 261,521 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $2.3K | 178,306 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $2.2K | 51,200 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.2K | 45,300 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $2.2K | 173,536 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $2.1K | 297,300 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.9K | 808,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.9K | 118,314 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $1.8K | 886,177 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $1.8K | 415,989 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.7K | 209,200 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $1.7K | 26,210 | 0.0% |
| Scynexis Inc | COM | 811292101 | $1.7K | 1,272,927 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $1.6K | 604,884 | 0.0% |